Eaton Vance Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $2.56M | Sell |
100,000
-165
| -0.2% | -$4.23K | ﹤0.01% | 977 |
|
|
2022
Q2 | $2.38M | Sell |
100,165
-2,464
| -2% | -$58.6K | ﹤0.01% | 1024 |
|
|
2022
Q1 | $2.31M | Buy |
102,629
+1,141
| +1% | +$25.7K | ﹤0.01% | 1130 |
|
|
2021
Q4 | $2.01M | Buy |
101,488
+226
| +0.2% | +$4.48K | ﹤0.01% | 1024 |
|
|
2021
Q3 | $1.97M | Sell |
101,262
-112
| -0.1% | -$2.18K | ﹤0.01% | 939 |
|
|
2021
Q2 | $2.23M | Buy |
101,374
+562
| +0.6% | +$12.4K | ﹤0.01% | 985 |
|
|
2021
Q1 | $2.4M | Buy |
100,812
+382
| +0.4% | +$9.09K | ﹤0.01% | 933 |
|
|
2020
Q4 | $2.63M | Buy |
100,430
+8
| +0% | +$209 | ﹤0.01% | 868 |
|
|
2020
Q3 | $1.75M | Sell |
100,422
-28
| -0% | -$487 | ﹤0.01% | 866 |
|
|
2020
Q2 | $1.69M | Buy |
100,450
+72
| +0.1% | +$1.21K | ﹤0.01% | 850 |
|
|
2020
Q1 | $1.19M | Buy |
100,378
+19
| +0% | +$226 | ﹤0.01% | 867 |
|
|
2019
Q4 | $1.21M | Sell |
100,359
-5
| -0% | -$60 | ﹤0.01% | 935 |
|
|
2019
Q3 | $1.42M | Buy |
100,364
+107
| +0.1% | +$1.51K | ﹤0.01% | 881 |
|
|
2019
Q2 | $1.12M | Buy |
+100,257
| New | +$1.12M | ﹤0.01% | 922 |
|